Chercheur, Institut Douglas
bruno_dot_giros_At_mcgill_dot_ca |
2012
Bacq A., Balasse L., Biala G., Guiard B., Gardier A. M., Schinkel A., Louis F., Vialou V., Martres M. P., Chevarin C., Hamon M., Giros B., Gautron S. (2012). Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response, Mol Psychiatry, 17(9), 926-39. En savoir plus.
Baudin A., Blot K., Verney C., Estevez L., Santamaria J., Gressens P., Giros B., Otani S., Dauge V., Naudon L. (2012). Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex, Neurobiol Learn Mem, 98(3), 207-14. En savoir plus.
Berthet A., Bezard E., Porras G., Fasano S., Barroso-Chinea P., Dehay B., Martinez A., Thiolat M. L., Nosten-Bertrand M., Giros B., Baufreton J., Li Q., Bloch B., Martin-Negrier M. L. (2012). L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor, J Neurosci, 32(2), 681-91. En savoir plus.
El Khoury M. A., Gorgievski V., Moutsimilli L., Giros B., Tzavara E. T. (2012). Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies, Prog Neuropsychopharmacol Biol Psychiatry, 38(1), 36-50. En savoir plus.
Farley S., Dumas S., El Mestikawy S., Giros B. (2012). Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801, Neuropharmacology, 62(1), 503-17. En savoir plus.
Fournet V., Schweitzer A., Chevarin C., Deloulme J. C., Hamon M., Giros B., Andrieux A., Martres M. P. (2012). The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances, J Neurochem, 121(1), 99-114. En savoir plus.
Fournet V., de Lavilleon G., Schweitzer A., Giros B., Andrieux A., Martres M. P. (2012). Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice, J Neurochem, 123(6), 982-96. En savoir plus.
Haenisch B., Drescher E., Thiemer L., Xin H., Giros B., Gautron S., Bonisch H. (2012). Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3, Naunyn Schmiedebergs Arch Pharmacol, 385(10), 1017-23. En savoir plus.